0001181431-12-039521.txt : 20120703 0001181431-12-039521.hdr.sgml : 20120703 20120703172806 ACCESSION NUMBER: 0001181431-12-039521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120629 FILED AS OF DATE: 20120703 DATE AS OF CHANGE: 20120703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Gregory CENTRAL INDEX KEY: 0001329505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 12946223 MAIL ADDRESS: STREET 1: 4 A CHESHAM STREET CITY: LONDON STATE: X0 ZIP: SW1X8DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd349998.xml 6/29/12 -- SALES X0306 4 2012-06-29 0 0001011835 MEDIVATION, INC. MDVN 0001329505 Bailey Gregory C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 1 0 0 0 Common Stock 2012-06-29 4 S 0 1500 88.67 D 345821 D Common Stock 2012-06-29 4 S 0 6500 89.72 D 339321 D Common Stock 2012-06-29 4 S 0 2000 90.40 D 337321 D Common Stock 2012-06-29 4 S 0 1000 91.54 D 336321 D Common Stock 2012-07-02 4 S 0 5500 93.40 D 330821 D Common Stock 2012-07-03 4 S 0 2000 95.17 D 328821 D The shares were sold at prices ranging from $88.64 to $88.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $89.20 to $90.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $93.05 to $93.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $95.05 to $95.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ C. Patrick Machado, Attorney-in-fact 2012-07-03